Results 201 to 210 of about 50,146 (330)

Long‐term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinoma

open access: yesBJUI Compass, Volume 7, Issue 1, January 2026.
Abstract Objectives To assess treatment outcomes and evaluate patient selection criteria for cytoreductive partial nephrectomy (CRPN) in a unique cohort of metastatic renal cell carcinoma (mRCC) patients. Methods A retrospective review of mRCC patients who underwent CRPN between 1995 and 2023 at a single institution was performed.
Andrea Lopez Sanmiguel   +9 more
wiley   +1 more source

Effect of tranexamic acid irrigation on perioperative blood loss during mini‐percutaneous nephrolithotomy: A pilot double‐blind randomised controlled trial

open access: yesBJUI Compass, Volume 7, Issue 1, January 2026.
Abstract Objective To evaluate the efficacy and safety of adding 0.1% tranexamic acid (TXA) to irrigation fluid in reducing perioperative blood loss during mini‐percutaneous nephrolithotomy (mini‐PCNL). Patients and Methods In this prospective, randomised study, 40 patients undergoing mini‐PCNL were allocated to receive irrigation fluid containing ...
Ornnicha Prohsoontorn   +6 more
wiley   +1 more source

Nanoparticle Albumin‐Bound Paclitaxel and Nivolumab for PD‐1 Inhibitor‐Refractory Recurrent or Metastatic Head and Neck Squamous‐Cell Carcinoma

open access: yesCancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Introduction Standard therapy for PD‐1 inhibitor‐refractory recurrent or metastatic head and neck squamous‐cell carcinoma (RM‐HNSCC) has limited activity. Drugs bound to albumin selectively target cancer cells with upregulated macropinocytosis, a process driven by constitutively hyper‐activated EGFR/RAS/PIK3CA signaling, which is common in ...
Douglas Adkins   +6 more
wiley   +1 more source

Hypospadias in a newborn puppy

open access: yes
Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Catherine Ennett, Marta Pereira
wiley   +1 more source

Home - About - Disclaimer - Privacy